CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage
Authors
Keywords
-
Journal
MOLECULES
Volume 24, Issue 24, Pages 4445
Publisher
MDPI AG
Online
2019-12-05
DOI
10.3390/molecules24244445
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Ribosome Biogenesis—Cancer Connection
- (2019) Marianna Penzo et al. Cells
- Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease
- (2019) Varsha Prakash et al. Nature Communications
- First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematological Cancers: Results of a Phase I Dose Escalation Study
- (2019) Amit Khot et al. Cancer Discovery
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Targeting of RNA Polymerase I Transcription Using CX-5461 in Combination with Radiation Enhances Tumour Cell Killing Effects in Human Solid Cancers
- (2019) Mohammed Ismael et al. Cancers
- Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma
- (2018) Quan Shen et al. MEDICAL SCIENCE MONITOR
- Targeting the ribosome biogenesis key molecule fibrillarin to avoid chemoresistance
- (2018) Btissame El Hassouni et al. CURRENT MEDICINAL CHEMISTRY
- Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
- (2018) Øyvind H. Hald et al. ONCOGENE
- Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer
- (2017) E. Giovannetti et al. SEMINARS IN CANCER BIOLOGY
- CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours
- (2017) Hong Xu et al. Nature Communications
- The relationship between the nucleolus and cancer: Current evidence and emerging paradigms
- (2016) Ines Orsolic et al. SEMINARS IN CANCER BIOLOGY
- FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer
- (2016) Chiara Caparello et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors
- (2015) Anneleen Daemen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial
- (2013) Michele Reni et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of RNA Polymerase I as a Therapeutic Strategy to Promote Cancer-Specific Activation of p53
- (2012) Megan J. Bywater et al. CANCER CELL
- Targeting RNA Polymerase I with an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth
- (2010) Denis Drygin et al. CANCER RESEARCH
- Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma
- (2008) Niccola Funel et al. LABORATORY INVESTIGATION
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started